147 related articles for article (PubMed ID: 21850284)
1. Interferon alfa and antiretroviral agents: a treatment option for adult T-cell leukemia/lymphoma.
Ishitsuka K; Tsukasaki K; Tamura K
Drugs Today (Barc); 2011 Aug; 47(8):615-23. PubMed ID: 21850284
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes.
Bazarbachi A; Plumelle Y; Carlos Ramos J; Tortevoye P; Otrock Z; Taylor G; Gessain A; Harrington W; Panelatti G; Hermine O
J Clin Oncol; 2010 Sep; 28(27):4177-83. PubMed ID: 20585095
[TBL] [Abstract][Full Text] [Related]
3. Overview of Targeted Therapies for Adult T-Cell Leukemia/Lymphoma.
Nasr R; Marçais A; Hermine O; Bazarbachi A
Methods Mol Biol; 2017; 1582():197-216. PubMed ID: 28357672
[TBL] [Abstract][Full Text] [Related]
4. [Development of future treatment for ATL].
Ishitsuka K
Rinsho Ketsueki; 2021; 62(7):766-773. PubMed ID: 34349061
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of adult T-cell leukemia/lymphoma.
Ishitsuka K
Semin Hematol; 2021 Apr; 58(2):114-122. PubMed ID: 33906721
[TBL] [Abstract][Full Text] [Related]
6. Biology and treatment of HTLV-1 associated T-cell lymphomas.
Tsukasaki K; Tobinai K
Best Pract Res Clin Haematol; 2013 Mar; 26(1):3-14. PubMed ID: 23768636
[TBL] [Abstract][Full Text] [Related]
7. Adult T-cell leukemia-lymphoma.
Tsukasaki K
Hematology; 2012 Apr; 17 Suppl 1():S32-5. PubMed ID: 22507774
[TBL] [Abstract][Full Text] [Related]
8. [Progress in the management of ATL].
Ishitsuka K
Rinsho Ketsueki; 2017; 58(6):676-682. PubMed ID: 28680001
[TBL] [Abstract][Full Text] [Related]
9. Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa.
Guery R; Suarez F; Lanternier F; Bougnoux ME; Lecuyer H; Avettand-Fenoel V; Sibon D; Frenzel L; Raphalen JH; Helias P; Renaudier P; Santa F; Lecuit M; Lortholary O; Hermine O; Aguilar C; Marçais A
Ann Hematol; 2021 Nov; 100(11):2813-2824. PubMed ID: 34387741
[TBL] [Abstract][Full Text] [Related]
10. Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).
Kchour G; Tarhini M; Kooshyar MM; El Hajj H; Wattel E; Mahmoudi M; Hatoum H; Rahimi H; Maleki M; Rafatpanah H; Rezaee SA; Yazdi MT; Shirdel A; de Thé H; Hermine O; Farid R; Bazarbachi A
Blood; 2009 Jun; 113(26):6528-32. PubMed ID: 19411628
[TBL] [Abstract][Full Text] [Related]
11. The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma.
White JD; Wharfe G; Stewart DM; Maher VE; Eicher D; Herring B; Derby M; Jackson-Booth PG; Marshall M; Lucy D; Jain A; Cranston B; Hanchard B; Lee CC; Top LE; Fleisher TA; Nelson DL; Waldmann TA
Leuk Lymphoma; 2001 Jan; 40(3-4):287-94. PubMed ID: 11426550
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the treatment of adult T-cell leukemia-lymphomas.
Utsunomiya A; Choi I; Chihara D; Seto M
Cancer Sci; 2015 Apr; 106(4):344-51. PubMed ID: 25613789
[TBL] [Abstract][Full Text] [Related]
13. A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.
Hermine O; Allard I; Lévy V; Arnulf B; Gessain A; Bazarbachi A;
Hematol J; 2002; 3(6):276-82. PubMed ID: 12522449
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma.
Cook LB; Rowan AG; Demontis MA; Sagawe S; Gillet NA; Melamed A; Greiller C; Witkover A; Bangham CRM; Taylor GP
Int J Hematol; 2018 Mar; 107(3):378-382. PubMed ID: 29090417
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.
Hermine O; Dombret H; Poupon J; Arnulf B; Lefrère F; Rousselot P; Damaj G; Delarue R; Fermand JP; Brouet JC; Degos L; Varet B; de Thé H; Bazarbachi A
Hematol J; 2004; 5(2):130-4. PubMed ID: 15048063
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic options for adult T-cell leukemia/lymphoma.
Marçais A; Suarez F; Sibon D; Frenzel L; Hermine O; Bazarbachi A
Curr Oncol Rep; 2013 Oct; 15(5):457-64. PubMed ID: 23943384
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia Lymphoma.
Tsukasaki K; Marçais A; Nasr R; Kato K; Fukuda T; Hermine O; Bazarbachi A
Front Microbiol; 2020; 11():1207. PubMed ID: 32636814
[TBL] [Abstract][Full Text] [Related]
18. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine.
Gill PS; Harrington W; Kaplan MH; Ribeiro RC; Bennett JM; Liebman HA; Bernstein-Singer M; Espina BM; Cabral L; Allen S
N Engl J Med; 1995 Jun; 332(26):1744-8. PubMed ID: 7760890
[TBL] [Abstract][Full Text] [Related]
19. Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research.
Tsukasaki K; Tobinai K
Clin Cancer Res; 2014 Oct; 20(20):5217-25. PubMed ID: 25320371
[TBL] [Abstract][Full Text] [Related]
20. How I treat adult T-cell leukemia/lymphoma.
Bazarbachi A; Suarez F; Fields P; Hermine O
Blood; 2011 Aug; 118(7):1736-45. PubMed ID: 21673346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
